SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific antibodies in different populations has remained unclear. Here, we report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seroreactivity was 0.26% in 387 hospitalize...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Commun
Asıl Yazarlar: Ng, Dianna L., Goldgof, Gregory M., Shy, Brian R., Levine, Andrew G., Balcerek, Joanna, Bapat, Sagar P., Prostko, John, Rodgers, Mary, Coller, Kelly, Pearce, Sandra, Franz, Sergej, Du, Li, Stone, Mars, Pillai, Satish K., Sotomayor-Gonzalez, Alicia, Servellita, Venice, Martin, Claudia Sanchez San, Granados, Andrea, Glasner, Dustin R., Han, Lucy M., Truong, Kent, Akagi, Naomi, Nguyen, David N., Neumann, Neil M., Qazi, Daniel, Hsu, Elaine, Gu, Wei, Santos, Yale A., Custer, Brian, Green, Valerie, Williamson, Phillip, Hills, Nancy K., Lu, Chuanyi M., Whitman, Jeffrey D., Stramer, Susan L., Wang, Candace, Reyes, Kevin, Hakim, Jill M. C., Sujishi, Kirk, Alazzeh, Fariba, Pham, Lori, Thornborrow, Edward, Oon, Ching-Ying, Miller, Steve, Kurtz, Theodore, Simmons, Graham, Hackett, John, Busch, Michael P., Chiu, Charles Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499171/
https://ncbi.nlm.nih.gov/pubmed/32943630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-18468-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller